Search for

Bibliographia Humboldtiana Index

Bibliographia Humboldtiana

III. Publications by Research Awardees

Medicine

Dolan, Prof. Dr. Raymond Joseph

University College London, United Kingdom
Field of research: Neurology
Host: Prof. Dr. Hans-Jochen Heinze Otto-von-Guericke-Universität Magdeburg
  • Moran RJ, Stephan KE, Seidenbecher T, Pape H-C, Dolan RJ, Friston KJ. : Dynamic causal models of steady-state responses. In: Neuroimage. 44, 2009, p. 796 - 811.

  • Bach D, Seymour B, Dolan RJ.: Neural activity associated with the passive prediction of ambiguity and risk for aversive events. In: Journal of Neuroscience. 29, 2009, p. 1648 - 1656.

  • Bach DR, Hulme O, Penny WD, Dolan RJ: The known unknowns: neural representation of second-order uncertainty, and ambiguity. In: Journal of Neuroscience. 31, 2011, p. 4811 - 4820.

  • Bach DR, Behrens TE, Garrido L, Weiskopf N, Dolan RJ.: Deep and superficial amygdala nuclei projections revealed in vivo by probabilistic tractography. In: Journal of Neuroscience. 31, 2011, p. 618 - 623.

  • Bach DR, Daunizeau J, Kuelzow N, Friston KJ, Dolan RJ.: Dynamic causal modeling of spontaneous fluctuations in skin conductance. In: Psychophysiology. 48, 2011, p. 252 - 257.

  • Bach DR, Talmi D, Hurlemann R, Patin A, Dolan RJ.: Automatic relevance detection in the absence of a functional amygdala. In: Neuropsychologia. 49, 2011, p. 1302 - 1305.

  • Bach DR, Daunizeau J, Friston KJ, Dolan RJ.: Dynamic causal modelling of anticipatory skin conductance responses. In: Biological Psychology. 85, 2010, p. 163 - 170.

  • Wunderlich K, Smittenaar P, Dolan RJ.: Dopamine enhances model-based over model-free choice behavior. In: Neuron. 75, 2012, p. 418 - 424.

  • Shiner T, Seymour B, Wunderlich K, Hill C, Bhatia KP, Dayan P, Dolan RJ.: Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. In: Brain. 135, 2012, p. 1871 - 1883.

  • Wunderlich K, Dayan P, Dolan RJ.: Mapping value based planning and extensively trained choice in the human brain. In: Nature Neuroscience. 15, 2012, p. 786 - 791.

  • Wunderlich K, Symmonds M, Bossaerts P, Dolan RJ.: Hedging your bets by learning reward correlations in the human brain. In: Neuron. 71, 2011, p. 1141 - 1152.

  • Bach DR, Flandin G, Friston KJ, Dolan RJ.: Modelling event-related skin conductance responses. In: International Journal of Psychophysiology. 75, 2010, p. 349 - 356.

  • Bach DR, Friston KJ, Dolan RJ.: Analytic measures for quantification of arousal from spontaneous skin conductance fluctuations. In: International Journal of Psychophysiology. 76, 2010, p. 52 - 55.

  • Bach DR, Flandin G, Friston K, Dolan RJ.: Time-series analysis for rapid event-related skin conductance responses. In: Journal of Neuroscience. 184, 2009, p. 224 - 234.

  • Bunzeck N, Guitart-Masip M, Dolan RJ, Duzel E.: Contextual novelty modulates the neural dynamics of reward anticipation. In: Journal of Neuroscience. 31, 2011, p. 12816 - 12822.

  • Campo P, Garrido M, Moran R, Maestu F, Garcia-Morales I, Gil-Nagel A, del Pozo F, Dolan RJ, Friston K.: Remote effects of hippocampal sclerosis on effective connectivity during working memory encoding: a case of connectional diaschis?. In: Cerebral Cortex. 22, 2012, p. 1225 - 1236.

  • Friston KJ, Bastos A, Litvak V, Stephan KE, Fries P, Moran RJ.: DCM for complex data: cross-spectra, coherence and phase-delays. In: Neuroimage. 59, 2012, p. 439 - 455.

  • Friston KJ, Shiner T, Fitzgerald T, Galea JM, Adams R, Brown H, Dolan RJ, Moran R, Stephan KE, Bestmann S.: Dopamine, Affordance and Active Inference. In: PLoS Computational Biology. 8(1), 2012, p. e1002327.

  • Guitart-Masip M, Huys Q, Fuentemilla L, Dayan P, Duzel E, Dolan R.: Go and No Go Learning in Reward and Punishment: Interactions between Affect and Effect. In: Neuroimage. 52, 2012, p. 154 - 166.

  • Guitart-Masip M, Chowdhury R, Sharot T, Dayan P, Dolan R, Duzel E.: Action controls dopaminergic enhancement of reward representations. In: Proceedings of National Academy of Sciences USA. 109, 2012, p. 7511 - 7516.

  • Guitart-Masip M, Beierholm UR, Dolan R, Duzel E, Dayan P.: Vigor in the Face of Fluctuating Rates of Reward: An Experimental Examination. In: Journal of Cognitive Neuroscience. 23, 2011, p. 3933 - 3938.

  • Guitart-Masip M, Fuentemilla L, Bach D, Huys Q, Dayan P, Dolan R, Duzel E.: Action dominates valence in the striatum and the dopaminergic midbrain. In: Journal of Neuroscinece. 31, 2011, p. 7867 - 7875.

  • Guitart-Masip M, Bunzeck N, Stephan KE, Dolan R, Duzel E.: Contextual novelty changes reward representations in the striatum. In: Journal of Neuroscience. 30, 2010, p. 1721 - 1726.

  • Guitart-Masip M, Talmi D, Dolan R.: Conditioned associations and economic decision biases. In: Neuroimage. 53, 2010, p. 206 - 214.

  • Huys QJ, Cools R, Golzer M, Friedel E, Heinz A, Dolan RJ, Dayan P.: Disentangling the roles of approach, activation and valence in instrumental and Pavlovian responding. In: PLoS Computational Biology . 7(4), 2011, p. e1002028.

  • Kurniawan IT, Guitart-Masip M, Dolan RJ.: Dopamine and effort-based decision making. In: Frontiers in Neuroscinece. 5, 2011, p. 81.

  • Moran RJ, Jung F, Kumagai T, Endepols H, Graf R, Dolan RJ, Friston KJ, Stephan KE, Tittgemeyer M.: Dynamic causal models and physiological inference: a validation study using isoflurane anaesthesia in rodents. In: PLoS One. 6(8), 2011, p. e22790.

  • Moran RJ, Symmonds M, Stephan KE, Friston KJ, Dolan RJ.: An in vivo assay of synaptic function mediating human cognition. In: Current Biology. 21, 2011, p. 1320 - 1325.

  • Moran RJ, Mallet N, Litvak V, Dolan RJ, Magill PJ, Friston KJ, Brown P.: Alterations in brain connectivity underlying beta oscillations in Parkinsonism. In: PLoS Computational Biology. 7(8), 2011, p. e1002124.

  • Moran RJ, Stephan KE, Dolan RJ, Friston KJ. : Consistent Spectral Predictors for Dynamic Causal Models of Steady State Responses. In: Neuroimage. 55, 2011, p. 1694 - 1708.

  • Moran RJ, Campo P, Maestu F, Reilly RB, Dolan RJ, Strange BA.: Peak frequency in the theta and alpha bands correlates with human working memory capacity. In: Frontiers in Human Neuroscience. 4, 2010, p. 200.

  • Schlagenhauf F, Rapp MA, Huys QJ, Beck A, Wustenberg T, Deserno L, Buchholz HG, Kalbitzer J, Buchert R, Kienast T, Cumming P, Plotkin M, Kumakura Y, Grace AA, Dolan RJ, Heinz A.: Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. In: Human Brain Mapping (Epub) . 2012.

  • Wright ND, Hodgson K, Fleming SM, Symmonds M, Guitart-Masip M, Dolan RJ.: Human responses to unfairness with primary rewards and their biological limits. In: Scientific Reports. 2, 2012, p. 593.

  • Wright ND, Symmonds M, Hodgson K, Fitzerald THB, Crawford B, Dolan RJ.: Approach-avoidance processes contribute to dissociable impacts of risk and loss on choice. In: Journal of Neuroscience. 32, 2012, p. 7009 - 7020.

  • Wright ND, Bahrami B, Johnson E, Di Malta G, Rees G, Frith CD, Dolan RJ.: Testosterone disrupts human collaboration by increasing egocentric choices. In: Proceedings of the Royal Society B: Biological Sciences. 279, 2012, p. 2275 - 2280.

Jeremic, Prof. Dr. Branislav

BioIRC - Bioengineering Research and Development Center, Serbia
Field of research: X-ray therapy, radiotherapy
Host: Prof. Dr. Michael Molls Technische Universität München
  • Branislav Jeremic, Dusan Milanovic, Nenad Filipovic: Combined Radiotherapy and Chemotherapy; Theoretical Considerations and Biological Premises. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 267 - 274.

  • Branislav Jeremic, Sinisa Stanic, Slobodan Milisvljevic: Conventional Rediation Therapy in Early Stage Non-small-cell Lung Cancer. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 315 - 342.

  • Branislav Jeremic, Francesc Casas, Asuncion Hervas-Moron: Radiochemotherapy in Locally Advanced Non-small-Cell Lung Cancer. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 409 - 432.

  • Branislav Jeremic, Zeljko Dobric, Francesc Casas: Limited-Disease Small-Cell Lung Cancer. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 491 - 504.

  • Branislav Jeremic, Luhua Wang: Radiation Therapy in Extensive Disease Small Cell Lung Cancer. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 505 - 512.

  • Branislav Jeremic, Zeljko Dobric: Radiation Therapy for Lung Cancer in Elderly. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 523 - 542.

  • Branislav Jeremic, Jai Prakash Agarwal, Sherif Abdel-Wahab: Radiation Therapy for Redurrent Disease. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 543 - 560.

  • Branislav Jeremic: Clinical Research in Radiation Oncology of Lung Cancer: Why We Fail(ed)?. In: Advances in Radiation Oncology in Lung Cancer - Second Edition. (Ed. Branislav Jeremic) Heidelberg: Springer, 2011, p. 809 - 818.

  • Hale Caglar, Francesc Casas, Luhua Wang, Branislav Jeremic.: Lung Cancer, In: (eds) , Springer, pp 91-106, 2014. In: Decision tools for radiation oncology. Prognosis, treatment response and toxicity. (Ed. Carsten N Nieder, Laurie Gaspar ) Heidelberg, Berlin: Springer, 2014, p. 91 - 106 [lung cancer].

  • Branislav Jeremic, Biljana Milicic. : Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. In: Am J Clin Oncol. 32, 2009, p. 163 - 168 [prognostic factors, survival, radiotherapy, chemotherapy, head and neck cancer].

  • Am J Clin Oncol: B. Jeremic, Biljana Milicic. Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. 32, 2009, p. 483 - 487 [prognostic factors, distant metastasis, radiotherapy, chemotherapy, head and neck cancer].

  • Michael MacManus, Ursula Nestle, Kenneth E. Rosenzweig, Ignaci Carrio, Christina Messa, Oleg Belohlavek, Massimo Danna, Tomio Inoue, Elisabeth Deniaud-Alexandre, Stefano Schipani, Naoyuki Watanabe, Maurizio Dondi, Branislav Jeremic.: Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007. 91: 85-94, 2009. In: Radiother Oncol. 91, 2009, p. 85 - 94 [PET, CT, radiotherapy, treatment planning].

  • Hiram A. Gay, Claudio H. Sibata, Ron R. Allison, Branislav Jeremic.: Isodose-Based Methodology for Minimizing the Morbidity and Mortality of Thoracic Hypofractionated Radiotherapy. In: Radiother Oncol. 91, 2009, p. 369 - 378 [morbidity, mortality, radiotherapy].

  • Jean-Pierre Pignon, Aurelie le Maître, Emilie Maillard, Jean Bourhis; MACH-NC Collaborative Group (130 authors/collaborators incl Jeremic B).: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17.346 patients. In: Radiother Oncol . 92, 2009, p. 4 - 14 [chemotherapy, head and neck cancer, meta analysis].

  • Lucyna Kepka, Francesc Casas, Branislav Perin, Sherif Abdel-Wahab, tatul Saghatelyan, Larisa Vashkevitch, Papa M. Gaye, David Dawotola, Jai P. Agarwal, Branislav Jeremic. : Radiochemotherapy for Lung Cancer in Developing Countries. In: Clin Oncol. 21, 2009, p. 536 - 542 [radiotherapy, lung cancer].

  • Lucyna Kepka, Arkadiusz Sprawka , Francesc Casas, Sherif Abdel-Wahab, Jai P. Agarwal , Branislav Jeremic. : Radiochemotherapy in Small-Cell Lung Cancer. In: Expert Rev Anticancer Ther. 9, 2009, p. 1379 - 1387 [radiotherapy, chemotherapy, lung cancer].

  • Lucyna Kepka, Arkadiusz Sprawka, Francesc Casas, Sherif Abdel-Wahab, Jai P. Agarwal, Branislav Jeremic. : Combined chemoradiotherapy in locally advanced non-small cell lung cancer. In: Expert Rev Anticancer Ther . 92, 2009, p. 1389 - 1403 [radiotherapy, chemotherapy, nonsmall cell lung cancer].

  • Francesc Casas, Lucyna Kepka, jai P. Agarwal, David Dawotola, Papa M. Gaye, Sherif Abdel-Wahab, Larisa Vashkevitch, Tatul Saghatelyan, Branislav Perin, Branislav Jeremic. : Radiochemotherapy in elderly with lung cancer. In: Expert Rev Anticancer Ther. 9, 2009, p. 1405 - 1411 [radiotherapy, chemotherapy, lung cancer, elderly].

  • Wilson Roa, James Z. Xing, Cormac Small, Rolf-Dieter Kortmann, Rene-Olivier Mirimannoff, Paul Okunieff, Yuta Shibamoto, Branislav Jeremic. : Current Development in the Radiotherapy Approach to Elderly and Frail Patients with Glioblastoma Multiforme. In: Expert Rev Anticancer Ther. 9, 2009, p. 1643 - 1650 [radiotherapy, elderly, frail patients, glioblastoma multiforme].

  • Vinay Sharma, Papa M. Gaye, Sherif Abdel-Wahab, Ntokozo Ndlovu, Twalib Ngoma, Verna Vanderpuye, Antonia Sowuhami, David A. Dawotola, Joseph Kigula-Mugambe, Branislav Jeremic.: Palliative radiation therapy practice for advanced esophageal carcinoma in Africa. In: Dis Esophagus. 23, 2010, p. 240 - 243 [palliation, radiotherapy, cancer of esophagus].

  • Branislav Jeremic, Francesc Casas, Luhua Wang, Branislav Perin.: Radiation Therapy for Early Stage (I/II) Non Small Cell Lung Cancer. In: Front Radiat Ther Oncol . 42, 2010, p. 87 - 93 [radiotherapy, early stage, nonsmall cell lung cancer].

  • Frank Zimmermann, Jorn Wulf, Ingmar Lax, Yasushi Nagata, Robert D. Timmerman, Igor Stojkovski, Branislav Jeremic.: Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer. In: Front Radiat Ther Oncol . 42, 2010, p. 94 - 114 [stereotactic body radiotherapy, early stage, nonsmall cell lung cancer].

  • Branislav Jeremic, Francesc Casas, Luhua Wang, Branislav Perin. : Radiochemotherapy in Extensive Disease Small Cell Lung Cancer ED-SCLC. In: Front Radiat Ther Oncol . 42, 2010, p. 180 - 186 [radiotherapy, chemotherapy, extensive disease, small cell lung cancer].

  • Branislav Jeremić B, Anushel Munshi, Francesc Casas, Igor Stojkovski, Zeljko Dobrić, Sundareen Banerjee, Jai P. Agarwal.: Surgery versus Radiotherapy in Early-Stage NSCLC. In: CML – Lung Cancer. 4, 2010, p. 37 - 43 [surgery, radiotherapy, early stage, nonsmall cell lung cancer].

  • Francesc Casas, Nuria Viñolas, Ferran Ferrer, Carles Agustí, Marcelo Sanchez, Josep M. Gimferrer, Francisco Lomeña, Marc Campayo, Branislav Jeremic.: Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer (NSCLC). In: J Thorac Oncol,. 69, 2011, p. 79 - 85 [radiotherapy, chemotherapy, stage III, nonsmall cell lung cancer].

  • Yasushi Nagata, Jorn Wulf, Ingmar Lax Robert Timmerman, Frank Zimmermann, Igor Stojkovski, Branislav Jeremic. : Stereotactic radiotherapy of primary lung cancer and other targets. Results of consultant meeting of the International Atomic Energy Agency (IAEA). In: Int J Radiat Oncol Biol Phys. 79, 2011, p. 660 - 669 [stereotactic radiotherapy, lung cancer].

  • Branislav Jeremić, Biljana Miličić, Slobodan Milisavljevic. : Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients. In: Cancer. 117, 2011, p. 2995 - 3003 [prognostic factors, stage III, nonsmall cell lung cancer, radiotherapy, chemotherapy].

  • Branislav Jeremic, Gregory Videtic.: Chest reirradiation with external beam radiotherapy for locally recurrent nonsmall cell lung cancer: a review. In: Int J Radiat Oncol Biol Phys. 80, 2011, p. 969 - 977 [chest reirradiation, local recurrence, lung cancer].

  • Branislav Jeremic, Biljana Milicic, Slobodan Milisavljevic.: Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC). Single institution experience in 600 patients. In: Int J Radiat Oncol Biol Phys. 82, 2012, p. 1157 - 1163 [radiotherapy, chemotherapy, stage III, nonsmall cell lung cancer].

  • Branislav Jeremic, Biljana Milicic, Slobodan Milisavljevic. : Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC). Single institution experience in 600 patients. In: Clin Translat Oncol. 14, 2012, p. 613 - 618 [side effects, radiotherapy, chemotherapy, stage III, nonsmall cell lung cancer].

  • Dusan Milanovic, Branislav Jeremic, Gian Kayser, Hans-Christian Rischke,Jens Pfeiffer, Michael Henke. : Relapsing high grade Mucoepidermoid Carcinoma: long lasting complete response following reirradiation and EGFR Blockade. In: Strahlenther Onkol. 188, 2012, p. 518 - 522 [recurrence, high grade, mucoepidermoid carcinoma, reirradiation, EFGR blockade].

  • Branislav Jeremic, Biljana Milicic, Slobodan Milisavljevic.: Radiotherapy alone versus radiochemotherapy in patients with favorable prognosis clinical stage IIIa nonsmall-cell lung cancer (NSCLC). In: Clin Lung Cancer. 14, 2013, p. 172 - 180 [radiotherapy, chemotherapy, stage IIIA, nonsmall cell lung cancer].

  • Branislav Jeremic, Alfredo Ramos Aguerri, Nenad Filipovic. : Radiosensitization by gold nanoparticles. In: Clin Translat Oncol. 15, 2013, p. 593 - 601 [radiosensitization, gold, nanoparticles].

  • Branislav Jeremic, Biljana Milicic, Slobodan Milisavljevic.: Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung. In: Clin Translat Oncol. 15, 2013, p. 747 - 753 [radiotherapy, chemotherapy, stage IIIA, adenocarcinoma, lung cancer].

  • Dusan Milanović, Branislav Jeremić, Anca-Ligia Grosu, Gerta Ruecker, Michael Henke.: Reirradiation plus EGFR inhibition in locally recurrent and unresectable head and neck cancer. Final results from a single institution. In: Strahlenther Onkol. 189, 2013, p. 842 - 848 [reirradiation, head and neck cancer, EGRF inhibition].

  • Audrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, Caroline Domerg, David Fisher, Rebecca Paulus, samithra J. Mandrekar, Chandra P. Belani, Frances A. Shepherd, Tim Eisen, Herbert Pang, Laurrence Collette, William T. Sause, Susanne E. Dahlberg, Jeffrey Crawford, Mary O'Brien, Steven E. Schild, Mahesh Parmar, Jane F. Tierney, Cecile Le Pechoux, Stefan Michiels; Surrogate Lung Project Collaborative Group (90 collaborators including Jeremic B.): Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. In: Lancet Oncology. 14, 2013, p. 619 - 626 [overall survival, radiotherapy, chemotherapy, locally advanced cancer, nonsmall cell lung cancer, meta analysis].

  • Branislav Jeremic, Verna Vanderpuye, Sherif Abdel-Wahab, Papa M. Gaye,Lotfi Kochbati, Msemo Diwani, Pelagia Emwula, Bernadette Oro, Kennedy Lishimpi, Joseph Kigula-Mugambe, David Dawotola , Tigeneh Wondemagegnehu, Catherine Nyongesa, Niam Oumar, Amr El-Omrani, Tarek Shuman, Lizanne Langenhoven, Lizelle Fourie. : Patterns of practice in palliative radiotherapy in Africa – case revisited. In: Clin Oncol. 26, 2014, p. 333 - 343 [patterns of practice, palliation, radiotherapy].

  • Nenad Filipovic Tijana Djukic, Milos Radovic, Danijela Cvetkovic, Milena Curcic, Snezana Markovic, Aleksandar Peulic, Branislav Jeremic. : Electromagnetic field investigation on different cancer cell lines. In: Cancer Cell International,. 14, 2014, p. 84 [electromagnetic fields, cancer, cell lines ].

  • Branislav Jeremic.: Standard treatment option in Stage III nonsmall cell lung cancer. Case against trimodality therapy and consolidation drug therapy. In: Clin Lung Cancer. 16, 2015, p. 80 - 85 [Stage III, nonsmall cell lung cancer, trimodality therapy, maintenance chemotherapy].

  • Jane A. Shaw, Elvis M. Irusen, Frank von Groote-Bidlingmeier, James M. Warwick, Branislav Jeremic, Rebecca Du Toit, Coenrad FN Koegelenberg.: Integrated PET-CT for evaluation of mediastinal lymph node staging of non-small cell lung cancer in a Tuberculosis-endemic area: a five year prospective observational study. In: S Afr Med J. 105, 2015, p. 145 - 150 [positron emission tomography, lymph nodes, lung cancer, tuberculosis].

  • Branislav Jeremic, Elena Fidarova, Vinay Sharma, Mohammed Faheem, Aly A. Ameira, Chiraz N. Ben- Ammar, Ana Frobe, Fee N. Lau, Stephen Brincat, Glenn Jones.: The International Atomic Energy Agency (IAEA) Randomized Trial of Palliative Treatment of incurable Locally Advanced non small cell lung cancer (NSCLC) using Radiotherapy (RT) and Chemotherapy (CHT) in Limited Resource Setting. In: Radiother Oncol. 116, 2015, p. 21 - 26 [palliation, nonsmall cell lung cancer, radiotherapy, chemotherapy].

  • Peter, Hoskin, Ana Rojas, Elena Fidarova, Rakesh Jalali,Ana M. Merino, Adela Poitevin, Seam Oucrif, Sherif Abdel-wahab, Lotfi Kochbati, Aista Plieskiene, Francesc Casas, Suzana Stojanovic, Guenther Schneider, Branislav Jeremic. : IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. In: Radiother Oncol. 116, 2015, p. 10 - 14 [bone metastasis, palliation, radiotherapy, a randomized trial].

  • Dorothy Lombe, Branislav Jeremic.: A Review of the Place and Role of Radiotherapy in Thymoma. In: Clin Lung Cancer. 16, 2015, p. 406 - 412 [radiotherapy, thymoma].

  • Branislav Jeremic.: State of the art in the treatment of lung cancer. In: S Afr Respir J,. 21, 2015, p. 59 - 65 [treatment, lung cancer].

  • Jose A. González-Ferreira, Juan J.Olasolo, Ignacio Azinovic, Branislav Jeremic .: Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. In: Rep Pract Oncol Radiother . 20, 2015, p. 328 - 339 [overall treatment time, radiotherapy, head and neck cancer].

  • Wilson Roa, Lucyna Kepka, Narendra Kumar, Valery Sinaika, Juliana Matiello, Darejan Lomidze, Dalenda Hentati, Douglas G. de Castro D, Katarzyna Dyttus-Cebulok, Suzanne Drodge, Sunita Ghosh, Branislav Jeremic, Eduardo Rosenblatt, Elena Fidarova. : An IAEA Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma Multiforme. In: J Clin Oncol. 33, 2015, p. 4145 - 4150 [elderly, frail patients, glioblastoma multiforme, radiotherapy, palliation, a randomized trial].

  • Virginie Rondeau, Jean-Pierre Pignon, Stefan Michiels; MACH-NC collaborative Group. (115 collaborators, including Jeremic B).: A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer. . 24:711-729, 2015. In: Stat Methods Med Res. 24, 2015, p. 711 - 729 [tumor progression, death, head and neck cancer, chemotherapy, meta analysis].

  • Branislav Jeremic, Francesc Casas, Pavol Dubinsky, Antonio Gomez-Caamano, Nikola Cihoric, Gregory Videtic. : Surgery in Stage IIIA nonsmall cell lung cancer: Lack of predictive and prognostic factors identifying any patient subgroup benefiting from it. In: Clin Lung Cancer. 17, 2016, p. 107 - 112 [Stage IIIA, nonsmall cell lung cancer, predictive factors, prognostic factors].

  • Nikola Cihoric, Alexandros Tsikkinis, Christina G. Miguelez, Vratislav Strnad, Ivan Soldatovic, Pirus Ghadjar, Branislav Jeremic, Alan Dal Pra, Daniel M. Aebersold, Kristina Lössl.: Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database. In: Radiat Oncol.. 11, 2016, p. 48 [clinical trials, brachytherapy, database].

  • Nikola Cihoric, Alexandros Tsikkinis , Giuseppe Minniti, Frank J. Lagerwaard, Ulrich Herrlinger, Etienne Mathier E; Ivan Soldatovic, Branislav Jeremic, Pirus Ghadjar, Olgun Elicin, Kristina Lössl, Daniel M. Aebersold, Claus Belka, Evelyn Herrmann, Maximilian Niyazi.: Current status and perspectives of interventional clinical trials for glioblastoma- analysis of ClinicalTrials.gov. In: Radiat Oncol. 12, 2017, p. 1 [interventional clinical trials, glioblastoma multiforme].

  • Branislav Jeremic, Francesc Casas, Pavol Dubinsky, Antonio Gomez-Caamano, Nikola Cihoric, Gregory Videtic, Miroslav Latinovic. : Combined modality therapy in Stage IIIA nonsmall cell lung cancer: clarity or confusion despite the highest level of evidence?. In: J Radiat Res. 58, 2017, p. 267 - 272.

  • Branislav Jeremic, Antonio Gomez-Caamano, Pavol Dubinsky, Nikola Cihoric, Francesc Casas, Nenad Filipovic : Radiation therapy in extensive stage small-cell lung cancer. In: Front Oncol. 7, 2017, p. 169 [radiotherapy, extensive disease, small cell lung cancer].

  • Branislav Jeremic. : Induction therapies plus surgery versus exclusive radiochemotherapy in Stage IIIA/pN2 nonsmall cell lung cancer (NSCLC). In: Am J Clin Oncol. 41, 2018, p. 267 - 273 [induction therapy, radiotherapy, chemotherapy, Stage IIIA, nonsmall cell lung cancer].

  • Branislav Jeremic, Francesc Casas, Pavol Dubinsky, Antonio Gomez-Caamano, Nikola Cihoric, Gregory Videtic, Ivan Igrutinovic.: Treatment-related predictive and prognostic factors in trimodality approach in Stage IIIA/N2 nonsmall cell lung cancer. In: Frontiers Oncol. 8, 2018, p. 30 [predictive factors, prognostic factors, Stage IIIA, nonsmall cell lung cancer, trimodality therapy].

  • Nikola Cihoric, Eugenia V. Badra, Alexandros Tsikkinis, Vikas Prasad, Stefanie Kroeze, Ivan Igrutinovic, Branislav Jeremic, Marcus Beck, Sebastian Zschaeck, Peter Wust,, Pirus Ghadjar.: Clinical trials involving positron emission tomography and prostate cancer: An analysis of the ClinicalTrials.gov database. In: Radiat Oncol. 13, 2018, p. 113 [clinical trials, positron emission tomography, prostate cancer, database].

  • Branislav Jeremic, Peter Hoskin. : Radiocemotherapy in common solid tumors: From developed to a developing world. In: Clin Oncol . 21, 2009, p. 513 - 514 [radiotherapy, chemotherapy, solid tumors].

  • Branislav Jeremic.: Activities in the field of lung cancer coordinated by the section of Applied Radiation Biology and Radiotherapy of the International Atomic Energy Agency. In: J Thorac Oncol. 4, 2009, p. 91 - 92 [lung cancer,radiotherapy, radiobiology].

  • Branislav Jeremic. : Radiochemotherapy in lung cancer: from reality to reality!?. In: Expert Rev on Anticancer Ther. 9, 2009, p. 1349 - 1351 [radiotherapy, chemotherapy, lung cancer].

  • Branislav Jeremic. : Concurrent radiochemotherapy in the treatment of cancer. The best you can offer to majority of your patients. In: Clin Transl Oncol. 12, 2010, p. 1 - 2 [radiotherapy, chemotherapy, cancer, treatment].

  • Branislav Jeremic. : Thoracic radiation therapy (TRT) in extensive disease small cell lung cancer (ED SCLC). In: Int J Radiat Oncol Biol Phys. 93, 2015, p. 7 - 9 [radiotherapy, extensive disease, small cell lung cancer].

  • Branislav Jeremic, Nikola Cihoric, Pavol Dubinsky, Nenad Filipovic.: Adjuvant immunotherapy in resected early nonsmall cell lung cancer. Battle lost, hopefully not the war!. In: J Thorac Disease. 8, 2016, p. 1886 - 1890 [adjuvant treatment, immunotherapy, resection, early stage, nonsmall cell lung cancer].

  • Jose S. Belderbos, Lucyna Kepka, Feng-Ming Kong, Mary K. Martel, Gregory M. Videtic, Branislav Jeremic. : Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion?. In: Int J Radiat Oncol Biol Phys. 74, 2009, p. 322 [elective nodal irradiation, locally advanced cancers, nonsmall cell lung cancer].

  • Branislav Jeremic, Gregory Videtic. : Induction chemotherapy inevitably leads to inferior outcome in combined modality treatment for unresectable stage III NSCLC. In: J Thorac Oncol . 7, 2012, p. 944 - 945 [induction treatment, chemotherapy, radiotherapy, stage III, nonsmall cell lung cancer].

  • Branislav Jeremic. : Radiochemotherapy in clinical Stage IIIA nonsmall cell lung cancer – effective and low toxic standard treatment option (in the absence of other proven treatments). In: J Thorac Oncol. 8, 2013, p. e99 [radiotherapy, chemotherapy, locally advanced cancers, nonsmall cell lung cancer].

  • Branislav Jeremic. : Radiochemotherapy as the standard treatment for both elderly and non-elderly fit patients with locally advanced (Stage III) Non-small cell lung cancer. In: Lung Cancer. 82, 2013, p. 176 [radiotherapy, chemotherapy, stage III, nonsmall cell lung cancer, elderly].

  • Branislav Jeremic. : Consolidation chemotherapy after concurrent radiochemotherapy in locally advanced nonsmall cell lung cancer may have been beneficial if we only knew where it have worked. In: J Thorac Oncol. 9, 2013, p. e7 [consolidation chemotherapy, radiotherapy, locally advanced cancers, nonsmall cell lung cancer].

  • Branislav Jeremic, Lizanne Langenhoven. : Consolidation therapy after concurrent radiochemotherapy? Still unclear who may potentially benefit!. In: Lung Cancer. 82, 2013, p. 509 [consolidation chemotherapy, radiotherapy].

  • Branislav Jeremic.: Concurrent radiochemotherapy in Stage IIIA non-small-cell lung cancer – not just effectiveness, but very low toxicity. In: Ann Thorac Surg. 97, 2014, p. 2228 [radiotherapy, chemotherapy, stage IIIA, nonsmall cell lung cancer, toxicity].

  • Branislav Jeremic. : Concurrent hyperfraxtionated radiation therapy (Hfx RT) and low-dose, daily chemotherapy (CHT) as effective and low toxic approach in locally advanced (Stage III) nonsmall cell lung cancer (NSCLC). In: Clin Lung Cancer. 15, 2014, p. e31 - e32 [radiotherapy, low dose chemotherapy, efficacy, toxicity, stage III, nonsmall cell lung cancer].

  • Nikola Cihoric, Nenad Filipovic, Branislav Jeremic. : A call for careful interpretation of outcome of nonsurgical approach in clinical stage IIIA non-small cell lung cancer in the National Cancer Database!. In: Ann Thorac Surg. 99, 2015, p. 1111 - 1112 [outcomes, nonsurgical approaches, stage IIIA, nonsmall cell lung cancer].

  • Nikola Cihoric, Branislav Jeremic. : Elective Nodal Irradiation in Early Non-Small Cell Lung Cancer. In: Int J Radiat Oncol Biol Phys. 91, 2015, p. 1111 - 1112 [elective nodal irradiation, early stage, nonsmall cell lung cancer].

  • Branislav Jeremic, Francesc Casas, Pavol Dubinsky, Nikola Cihoric, Antonio Gomez-Caamano. : Trimodality treatment approach in stage III/pN2 nonsmall cell lung cancer. "Usually appropriate" may well be very inappropriate treatment option. In: Am J Clin Oncol. 38, 2015, p. 645 [trimodality treatment, stage IIIA, nonsmall cell lung cancer].

  • Branislav Jeremic, Nenad Filipovic, Biljana Milicic, Slobodan Milisavljevic. : Radiation therapy (RT) and chemotherapy (CHT) in Stage II nonsmall cell lung cancer (NSCLC) : Clinical entity neglected by radiation oncologists?. In: Lung Cancer. 90, 2015, p. 622 - 623 [stage II, nonsmall cell lung cancer, radiotherapy].

  • Branislav Jeremic, Nikola Cihoric, Francesc Casas, Antonio Gomez - Caamano, Pavol Dubinsky. : No Role For Trimodality Therapy And Consolidation Chemotherapy When Compared To Concurrent Radiochemotherapy Alone In Stage III Nonsmall Cell Lung Cancer. In: J Clin Oncol. 34, 2016, p. 196 - 197 [trimodality therapy, consolidation chemotherapy, stage III, nonsmall cell lung cancer].

  • Nikola Cihoric, Alexandros Tsikkinis, Nenad Filipovic, Branislav Jeremic.: Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery. Yes, radiation therapy, too!. In: Eur Resp J. 48, 2016, p. 276 - 278 [locoregional recurrence, surgery, radiotherapy, nonsmall cell lung cancer].

  • Branislav Jeremic, Antonio Gomez-Caamano, Pavol Dubinsky, Nikola Cihoric, Ivan Igrutinovic, Gregory Videtic.: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- Ain't no mountain high enough…. to keep me getting to you. In: Lung Cancer. 123, 2018, p. 172 - 173 [multimodlaity treatment, radiotherapy, chemotherapy, surgery, stage IIIA, nonsmall cell lung cancer].

  • Igor Stojkovski, Francesc Casas, Papa M. Gaye, Sherif Abdel-Wahab, Branislav Jeremic. : Concurrent paclitaxel and radiotherapy. Lung cancer as a model for successful implementation. In: Herbal medicine; A cancer chemopreventive and therapeutic perspective,. (Ed. Rajesh Arora) Delhi : Jaypee Brothers Medical Publishers Pvt. Ltd,, 2009, p. 333 - 347 [radiotherapy, paclitaxel, lung cancer].

  • Branislav Jeremic, Francesc Casas, Igor Stojkovski, Slobodan Milisavljevic, Zeljko Dobric.: Lung Cancer. In: Reirradiation – new frontiers. (Ed. Carsten N. Nieder, Hans Langendijk.) Heidelberg: Springer, 2010, p. 117 - 130 [lung cancer, reirradiation].

  • Francesc Casas, Sherif Abdel-Wahab, Nenad Filipovic, Branislav Jeremic. : Radiation therapy. In: International encyclopedia of public health (2nd edition). (Ed. Stela R. Quah, William C Cockerham ) New York: Elsevier, 2017, p. 260 - 268 [cancer, treatment, radiotherapy].

  • Branislav Jeremić, Francesc Casas, Sherif Abdel-Wahab, Nikola Cihoric, Pavol Dubinsky P, Ana M. Merino, Luhua Wang .: Lung Cancer. In: Reirradiation - New frontiers (2nd ed),. (Ed. Carsten N. Nieder C, Johannes Langendijk.) Heildeberg: Springer, 2017, p. 185 - 208 [reirradiation, lung cancer].

Lang, Prof. Dr. med. Karl Sebastian

Universität Duisburg-Essen, Germany
Field of research: Hepatology
Host: Prof. Dr. Jan Buer Universität Duisburg-Essen
  • Karl Sebastian Lang, PA Lang, D Graf, KM Boini, K Klingel, R Kandolf, F Lang: Cell volume, the serum and glucocorticoid intucible kinase 1 and the liver. In: Z Gastroenterol.. 49 (6), 2011, p. 713 - 719.

  • Karl Sebastian Lang, XH Nguyen, PA Lang, D Adam, G Fattakhova, N Föger, MA Kamal, P Prilla, S Mathieu, C Wagner, T Mak, AC Chan, KH Lee: Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. In: Blood. 118 (3), 2011, p. 598 - 608.

  • Karl Sebastian Lang, C Ehlting, N Ronkina, O Böhmer, U Albrecht, KA Bode, A Kotlyarov, D Radzioch, M Gaestel, D Häussinger, JG Bode: Distinct functions of the mitogenactivated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK" mediates lipopolysaccharide-induced signal tranducers . In: J Biol Chem. 286 (27), 2011, p. 24113 - 24124.

  • Karl Sebastian Lang, PA Lang, M Recher, D Häussinger: Genes determining the course of virus persistence in the liver: lessons from murine infection with lymphocytic choriomeningitis virus. In: Cell Physiol Biochem. 26 (3), 2010, p. 263 - 272.

  • Karl Sebastian Lang, PA Lang, D Merkler, P Funkner, N Shaabani, A Meryk, C Krings, C Barthuber, M Recher, W Brück, D Häussinger, PS Ohashi: Oxidized ATP inhibits T-Cell-mediated autoimmunity. In: Eur J Immunol.. 40 (9), 2010, p. 2401 - 2408.

  • Karl Sebastian Lang, AA Navarini, M Krzyzowska, E Horvath, H Hengartner, MG Niemialtowski, RM Zinkernagel: Long-lastig immunity by early infection of maternal-antibody-protected infants. In: Eur J Immunol. 40 (1), 2010, p. 113 - 116.

  • Merches K, Khairnar V, Knuschke T, Shaabani N, Honke N, Duhan V, Recher M, Navarini AA, Hardt C, Häussinger D, Tümmler B, Gulbins E, Futerman AH, Hoffmann D, Lang F, Lang PA, Westendorf AM, Lang KS.: Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection. In: Cell Physiol Biochem. 36, 2015, p. 2379 - 92.

  • Shaabani N, Honke N, Dolff S, Görg B, Khairnar V, Merches K, Duhan 4, Metzger S, Recher M, Barthuber C, Hardt C, Proksch P, Häussinger D, Witzke O, Lang PA, Lang KS: IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus. In: J Autoimmun. 62, 2015, p. 11 - 21 [Autoantibodies; Fcgr2b; IFN-γ; Infection; Inflammation; Systemic lupus erythematosus; Virus].

  • Lang KS, Johnson TJ: Transcriptome modulations due to A/C2 plasmid acquisition. In: Plasmid. 80, 2015, p. 83 - 9 [A/C2; Crosstalk; Gene expression; HGT; RNA-Seq].

  • Khairnar V, Duhan V, Maney SK, Honke N, Shaabani N, Pandyra AA, Seifert M, Pozdeev V, Xu HC, Sharma P, Baldin F, Marquardsen F, Merches K, Lang E, Kirschning C, Westendorf AM, Häussinger D, Lang F, Dittmer U, Küppers R, Recher M, Hardt C, Scheffrahn I, Beauchemin N, Göthert JR, Singer BB, Lang PA, Lang KS: CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. In: Nat Commun. 18, 2015.

  • Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, Shinde P, McIlwain DR, Maney SK, Gommerman J, Löhning M, Ohashi PS, Mak TW, Pieper K, Sic H, Speletas M, Eibel H, Ware CF, Tumanov AV, Kruglov AA, Nedospasov SA, Häussinger D, Recher M, Lang KS, Lang PA: Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. In: J Virol. 89, 2015, p. 4748 - 59.

  • McIlwain DR, Grusdat M, Pozdeev VI, Xu HC, Shinde P, Reardon C, Hao Z, Beyer M, Bergthaler A, Häussinger D, Nolan GP, Lang KS, Lang PA: T-cell STAT3 is required for the maintenance of humoral immunity to LCMV. In: Eur J Immunol. 45, 2015, p. 418 - 27 [Chronic infection; Humoral immunity; LCMV; STAT3; T follicular helper cells].

  • Lang PA, Meryk A, Pandyra AA, Brenner D, Brüstle A, Xu HC, Merches K, Lang F, Khairnar V, Sharma P, Funkner P, Recher M, Shaabani N, Duncan GS, Duhan V, Homey B, Ohashi PS, Häussinger D, Knolle PA, Honke N, Mak TW, Lang KS: Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection. In: Cell Death Differ. 22, 2015, p. 164 - 73.

  • Xu HC, Grusdat M, Pandyra AA, Polz R, Huang J, Sharma P, Deenen R, Köhrer K, Rahbar R, Diefenbach A, Gibbert K, Löhning M, Höcker L, Waibler Z, Häussinger D, Mak TW, Ohashi PS, Lang KS, Lang PA: Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. In: Immunity. 40, 2014, p. 949 - 60.

  • Grusdat M, McIlwain DR, Xu HC, Pozdeev VI, Knievel J, Crome SQ, Robert-Tissot C, Dress RJ, Pandyra AA, Speiser DE, Lang E, Maney SK, Elford AR, Hamilton SR, Scheu S, Pfeffer K, Bode J, Mittrücker HW, Lohoff M, Huber M, Häussinger D, Ohashi PS, Mak TW, Lang KS, Lang PA: IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV. In: Cell Death Differ. 21, 2014, p. 1050 - 60.

  • Brenner D, Brüstle , Lin GH, Lang PA, Duncan GS, Knobbe-Thomsen CB, St Paul M, Reardon C, Tusche MW, Snow B, Hamilton SR, Pfefferle A, Gilani SO, Ohashi PS, Lang KS, Mak TW: Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells. In: Proc Natl Acad Sci U S A. 111, 2014, p. 1060 - 5 [Th1/Th17 cells; inflammation].

  • Honke N, Shaabani N, Zhang DE, Iliakis G, Xu HC, Häussinger D, Recher M, Löhning M, Lang PA, Lang KS: Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. In: PLoS Pathog. 9, 2013.

  • Lang KS, Lang PA, Meryk A, Pandyra AA, Boucher LM, Pozdeev VI, Tusche MW, Göthert JR, Haight J, Wakeham A, You-Ten AJ, McIlwain DR, Merches K, Khairnar V, Recher M, Nolan GP, Hitoshi Y, Funkner P, Navarini AA, Verschoor A, Shaabani N, Honke N, Penn LZ, Ohashi PS, Häussinger D, Lee KH, Mak TW: Involvement of Toso in activation of monocytes, macrophages, and granulocytes. In: Proc Natl Acad Sci U S A. 110, 2013, p. 2593 - 8.

  • Lang PA, Xu HC, Grusdat M, McIlwain DR, Pandyra AA, Harris IS, Shaabani N, Honke N, Maney SK, Lang E, Pozdeev VI, Recher M, Odermatt B, Brenner D, Häussinger D, Ohashi PS, Hengartner H, Zinkernagel RM, Mak TW, Lang KS: Reactive oxygen species delay control of lymphocytic choriomeningitis virus. In: Cell Death Differ. 20, 2013, p. 649 - 58.

  • Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, Trilling M, Klingel K, Sauter M, Kandolf R, Gailus N, van Rooijen N, Burkart C, Baldus SE, Grusdat M, Löhning M, Hengel H, Pfeffer K, Tanaka M, Häussinger D, Recher M, Lang PA, Lang KS: Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. In: Nat Immunol. 13, 2011, p. 51 - 7.

Lang, Prof. Dr. Philipp Alexander

Heinrich-Heine-Universität Düsseldorf, Germany
Field of research: Hepatology
Host: Prof. Dr. Dieter Häussinger Heinrich-Heine-Universität Düsseldorf
  • Philipp Alexander Lang, N. Honke, N. Shaabani, G. Cadeddu, U. R. Sorg, D. E. Zhang, M. Trilling, K. Klingel, M. Sauter, R. Kandolf, N. Gailus, n. van Rooijen, C. Burkart, S. E. Baldus, M. Gusdat, M. Löhning, H. Hengel, K. Pfeffer, M. Tanaka, D. Häussinger, M. Recher, K. S. Lang: Enforced viral replication activates adaptive immunity and is essential for the control of a cytophatic virus. In: Nat Immunol. 13 (1), 2011, p. 51 - 57.

  • Philipp Alexander Lang, D. Graf, K. M. Boini, K. S. Lang, K. Klingel, R. Kandolf, F. Z. Lang: Cell volume, the serum and glucocorticoid inducible kinase 1 and the liver. In: Gastroenterol.. 49 (6), 2011, p. 713 - 719.

  • Brüstle A., Brenner D., Knobbe CB, Lang Philipp Alexander, Virtanen C, Hershenfield BM, Reardon C., Lacher SM, Ruland J, Ohashi PS, Mak TW : The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells . In: The Journal of clinical investigation. 2012, p. 4698 - 4709.

  • Chen G, Dimitriou I, Milne L, Lang KS, Lang Philipp Alexander, Fine N, Ohashi PS, Kubes P, Rottapel R. : The 3BP2 adapter protein is required for chemoattractant-mediated neutrophil activation . In: Journal of immunology. 2012, p. 2138 - 2150.

  • Kaesler S, Sobiesiak M, Kneilling M, Volz T, Kempf WE, Lang Philipp Alexander, Lang KS, Wieder T, Heller-Stilb B, Warskulat U, Häussinger D, Lang F, Biedermann T : Effective T-cell recall responses require the taurine transporter Taut . In: European journal of immunology. 2012, p. 831 - 841.

  • Shaabani N, Honke N, Lang Philipp Alexander, Görg B, Proksch P, Gailus N, Gotoh T, Häussinger D, Lang KS : Tunicamycin inhibits diabetes. In: Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry and pharmacology. 2012, p. 595 - 602.

  • Recher M, Burns SO, de la Fuente MA, Volpi S, Dahlberg C, Walter JE, Moffitt K, Mathew D, Honke N, Lang Philipp Alexander, Patrizi L, Falet H, Keszei M, Mizui M, Csizmadia E, Candotti F, Nadeau K, Bouma G, Delmonte OM, Frugoni F, Fomin AB, Buchbinder D, Lundequist EM, Massaad MJ, Tsokos GC, Hartwig J, Manis J, Terhorst C, Geha RS, Snapper S, Lang KS, Malley R, Westerberg L, Thrasher AJ, Notarangelo LD: B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. In: Blood. 2012, p. 2819 - 2828.

  • McIlwain DR, Lang Philipp Alexander, Maretzky T, Hamada K, Ohishi K, Maney SK, Berger T, Murthy A, Duncan G, Xu HC, Lang KS, Häussinger D, Wakeham A, Itie-Youten A, Khokha R, Ohashi PS, Blobel CP, Mak TW: iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS . In: Science. 2012, p. 229 - 232.

  • Hao Z, Duncan GS, Su YW, Li WY, Silvester J, Hong C, You H, Brenner D, Gorrini C, Haight J, Wakeham A, You-Ten A, McCracken S, Elia A, Li Q, Detmar J, Jurisicova A, Hobeika E, Reth M, Sheng Y, Lang Philipp Alexander, Ohashi PS, Zhong Q, Wang X, Mak TW : The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis . In: The Journal of experimental medicine . 2012, p. 173 - 186.

  • Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang Philipp Alexander, Ambagala T, Pellegrini M, Calzascia T, Aidarus N, Elford AR, Yue FY, Kremmer E, Kovacs CM, Benko E, Tremblay C, Routy JP, Bernard NF, Ostrowski MA, Ohashi PS, Watts TH : Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection . In: The Journal of experimental medicine . 2012, p. 77 - 91.

  • Lang Philipp Alexander, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, Elford AR, Dhanji S, Shaabani N, Tran CW, Dissanayake D, Rahbar R, Ghazarian M, Brüstle A, Fine J, Chen P, Weaver CT, Klose C, Diefenbach A, Häussinger D, Carlyle JR, Kaech SM, Mak TW, Ohashi PS: Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. In: Proceedings of the National Academy of Sciences of the United States of America . 2012, p. 1210 - 5.

Mantzoros, Prof. Dr. Christos

Harvard Medical School, United States of America
Field of research: Endocrinology
Host: Prof. Dr. Matthias Blüher Universität Leipzig
  • S. Bluher, C.S. Mantzoros : Leptin in humans: lessons from translational research. In: American Journal of Clinical Nutrition.. 89, 2009, p. 991S - 997S [leptin, obesity, metabolism].

  • H.K. Berthold, E. Giannakidou, W. Krone, C.S. Mantzoros, I. Gouni-Berthold : The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. In: Clinica Chimica Acta. 399(1-2), 2009, p. 112 - 116 [ghrelin, obesity, metabolism].

  • Christos Mantzoros: Nutrition and Metabolism: Underlying Mechanisms and Clinical Consequences. Totowa, NJ: Humana Press, 2009, 428 pp. [nutrition and metabolism].

Rumiati, Prof. Dr. Raffaella

Scuola Internazionale Superiore di Studi Avanzati in Trieste, Italy
Field of research: Neurology
Host: Prof. Dr. Karl Zilles Forschungszentrum Jülich GmbH
  • Civai, C., Crescentini, C., Rustichini, A. & Rumiati, R.I. : Equality versus self-interest in the brain: differential roles of anterior insula and medial prefrontal cortex. In: Neuroimage. 62, 2012, p. 102 - 112 [Ultimatum Game].

Schnermann, Prof. Dr. Dr. h.c. Jürgen

National Institutes of Health (NIH), United States of America
Field of research: Renal physiology
Host: Prof. Dr. Armin Kurtz Universität Regensburg
  • Mona Oppermann, Isabel Carota, Ina Schiessl, Christoph Eisner, Hayo Castrop and Jürgen Schnermann: Direct assessment of tubuloglomerular feedback responsiveness in connexin 40-deficient mice. In: American Journal of Physiology Renal Physiology. 304, 2013, p. F1181 - F1186 [Micropuncture, stop-flow pressure, genetic background, vascular resistance].

Sun, Prof. Dr. Taolei

Wuhan University of Technology, People's Republic of China
Field of research: Medical biochemistry
Host: Prof. Dr. Harald Fuchs Westfälische Wilhelms-Universität Münster
  • Taolei Sun, Guangyan Qing, Xing Wang, Lei Jiang, Harald Fuchs: Saccharide-Sensitive Wettability Switching on a Smart Polymer Surface. In: Soft Matter. 5, 2009, p. 2759 - 2765.

  • Taolei Sun, Guangyan Qing, Xing Wang, Harald Fuchs: Nucleotide-Responsive Wettability on a Smart Polymer Surface. In: Journal of the American Chemical Society. 131, 2009, p. 8370 - 8371.

  • Taolei Sun, Hui Gan, Kangjian Tang, Michael Hirtz, Yong Li, Lifeng Chi, Stefan Butz, Harald Fuchs: Selective Adsorption of DNA on Chiral Surfaces: Supercoiled or Relaxed Confirmation. In: Angewandte Chemie-International Edition. 48, 2009, p. 5282 - 5286.

  • Taolei Sun, Xing Wang, Hui Gan, Baolian Su, Harald Fuchs, Dietmar Vestweber, Stefan Butz: Stereochemistry Triggered Differential Cell Behaviours on Chiral Polymer Surfaces. In: Soft Matter. 6, 2010, p. 3851 - 3855.

  • Taolei Sun, Guangyan Qing, Hai Xiong, Frank Seela: Spatially Controlled DNA Nanopatterns by "Click" Chemistry Using Oligonucleotides with Different Anchoring Sites. In: Journal of the American Chemical Societie. 132, 2010, p. 15228 - 15232.

  • Taolei Sun, Xing Wang, Hui Gan: The influence of Surface Chirality on Protein Adsorption. In: Advanced Functional Materials. 21, 2011, p. 3276 - 3281.

  • Taolei Sun, Guangyan Qing: Chirality-Triggered Wettability Switching on Smart Polymer Surface. In: Advanced Materials. 23, 2011, p. 1615 - 1620.

  • Taolei Sun, Guangyan Qing: Biomimetic Smart Interface Materials for Biological Applications. In: Advanced Materials. 23, 2011, p. H57 - H77.

  • Taolei Sun, Guangyan Qing, Baolian Su, Lei Jiang: Functional Biointerface Materials Inspired from Nature. In: Chemical Society Reviews. 40, 2011, p. 2909 - 2921.

  • Taolei Sun, Xing Wang, Hui Gan, Mingxi Zhang: Modulating cell behaviours on chiral polymer brush films with different hydrophobic side groups. In: Langmuir. 28 (5), 2012, p. 2791 - 2798.

  • Taolei Sun, Guangyan Qing: The Transformation of Chiral Signals into Macroscopie Properties of Materials Using Chirality-Responsive Polymers. In: NPG Asia Materials (DOI:10.1038/am.2012.6). 4, 2012.

  • Taolei Sun, Mingxi Zhang, Guangyan Qing: Chiral Biointerface Materials. In: Chemical Society Review. 41, 2012, p. 1972 - 1984.

Velazquez-Perez, Prof. Dr. Luis

Academia de Ciencias de Cuba, Cuba
Field of research: Neurophysiology
Host: Prof. Dr. Georg Auburger Johann Wolfgang Goethe-Universität Frankfurt am Main
  • Luis Velazquez-Perez: Spinocerebellar Ataxia Type 2. Diagnosis, Prognosis and evolution. La Habana: ECIMED, 2012, 117 pp. [Spinocerebellar Ataxias, SCA2, Clinical manifestations, electrophysiological alterations, physiopathology, presymptomatic abnormalities, clinical diagnosis.].

  • Luis Velazquez-Perez and Roberto Rodriguez-Labrada: Early manifestations of Spinocerebellar Ataxias type 2. Holguin: Ediciones Holguin, 2012, 115 pp. [SCA2, presymptomatic alterations, precerebellar manifestations, aerly clinical manifestations, saccadic alterations, electrophysiological abnormalities].

Walker, Prof. Dr. Lary C.

Emory University, United States of America
Field of research: Medical neurobiology
Host: Prof. Dr. Mathias Jucker Eberhard Karls Universität Tübingen
  • Ye L, Rasmussen J, Kaeser SA, Marzesco AM, Obermuller U, Mahler J, Schelle J, Odenthal J, Kruger C, Fritschi SK, Walker LC, Staufenbiel M, Baumann F and Jucker M.: Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis. In: EMBO Reports. 18, 2017, p. 1536 - 1544 [Alzheimer's disease Neurology Neuropathology].

  • Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Häsler LM, Baumann F, Nyström S, Portelius E, Blennow K, Lashley T, Fox NC, Sepulveda-Falla D, Glatzel M, Oblak AL, Ghetti B, Nilsson KPR, Hammarström P, Staufenbiel M, Walker LC and Jucker M.: Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. In: Proc Natl Acad Sci U S A. 114, 2017, p. 13018 - 13023 [Neurology Neuropathology].

  • Walker LC and Jucker M. : The Exceptional Vulnerability of Humans to Alzheimer's Disease. In: Trends in Molecular Medicine. 23, 2017, p. 534 - 545 [Neurology Neuropathology Comparative Neuroscience].

  • Walker LC : Proteopathic strains and the heterogeneity of neurodegenerative diseases. In: Annual Review of Genetics. 50, 2016, p. 329 - 346 [Alzheimer's disease Genetics Neurology Neuropathology].

  • Rasmussen J, Jucker M and Walker LC: Aβ Seeds and Prions: How Close the Fit?. In: Prion. 11, 2017, p. 215 - 225 [Alzheimer's disease Creutzfeldt-Jakob disease Neurology Neuropathology].

  • Walker, LC: Prion-like protein seeding and the pathobiology of Alzheimer's disease. In: Protein Folding Disorders in the Central Nervous System. (Ed. J Ghiso, A Rostagno) Singapore: World Scientific, 2018, p. 57 - 82 [Neurology Neuropathology Neurodegenerative disease].

  • Walker LC: Prion-like mechanisms in Alzheimer disease. In: Human Prion Diseases, Handbook of Clinical Neurology, Vol 153 (3rd series). (Ed. Maurizio Pocchiari, Jean Manson) Amsterdam: Elsevier, 2018, p. 303 - 319 [Alzheimer's disease, Abeta, amyloid, neurodegeneration, prion disease, tauopathy ].

  • Walker LC, Lynn DG and Chernoff YO: A standard model of Alzheimer's disease?. In: Prion. Sep 17, 2018, p. 1 - 5 [Abeta Alzheimer's disease amyloid cascade prion seeding].

  • Jucker M and Walker LC: Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. In: Nature Neuroscience. 21, 2018, p. 1341 - 1349 [Alzheimer's disease amyloid neurodegeneration Parkinson's disease prion seeding synucleinopathy tauopathy].

Webster, Prof. Dr. Henry de Forest


Field of research: Neurology
Host: Prof. Dr. Ralf Schober Universität Leipzig
  • Henry de Forest Webster, Karl E. Aström: Gliogenesis: Historical Perspectives, 1839-1985. Berlin: Springer Verlag, 2009, 108 pp.

Westbrook, Prof. Dr. Gary Lee

Oregon Health & Science University, United States of America
Field of research: Neurophysiology

  • Didier De Saint Jan, Daniela Hirnet, Gary L Westbrook, Serge Charpak: External tufted cells drive the output of olfactory bulb glomeruli. In: The Journal of Neuroscience. 29, 2009, p. 2043 - 2052 [synaptic transmission, neural circuits, neuroscience, hippocampus, olfactory system].